Rivaroxaban versus warfarin for the management of left ventricle thrombus

BACKGROUND: Rivaroxaban has been recently introduced for the management of non-valvular intra-cardiac thrombosis with variable results. We aimed to compare the results of the off-label use of rivaroxaban versus warfarin in the management of patients with left ventricle (LV) thrombus. This research i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Egypt Heart J
Hlavní autoři: Albabtain, Monirah A., Alhebaishi, Yahya, Al-Yafi, Ola, Kheirallah, Hatim, Othman, Adel, Alghosoon, Haneen, Arafat, Amr A., Alfagih, Ahmed
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088413/
https://ncbi.nlm.nih.gov/pubmed/33932172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43044-021-00164-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky